Global Human Embryonic Stem Cells Market, By Product Type (Totipotent Stem Cell, Pluripotent Stem Cell, Unipotent stem Cell), By Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, and Toxicology Testing) By End User (Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, Others) and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2027.
Global Human Embryonic Stem Cells Market
Global Human Embryonic Stem Cells Market was valued at USD 1060.2 million in 2021 which expected to reach at USD 1897.6 million by 2027 at a CAGR 9.93% from 2022-2027.Human embryonic stem cell come from embryos & they are pluripotent and about 3-5 days old. They are very versatile as they have ability to divide themselves into more stem cells & can even become any type of cell in the human body and can be used to regenerate/repair any diseased tissue or organs.
Market Drivers
The rise in focus on the development of stem cell therapies across the globe. Moreover, increase in prevalence of cardiac and malignant diseases are prominent driving factors which expected to boost the growth of global human embryonic stem cells market over the forecast period.
 Furthermore, growing demand for regenerative medicines across the globe is expected to propel the growth of the market. For instance, in Feb 2022, in an effort to support the R & D (Research & Development) in regenerative medicine in the country, the Government of India has helped setting up state-of-the-art stem cell research facilities in 40 premier health research & educational institutions. It has also spent around Rs. 8.13 crore through ICMR (Indian Council of Medical Research) under certain projects. Moreover, increase in government initiatives will create lucrative opportunity for global human embryonic stem cells market. 
Market Restraints
High cost of the procedure is a major restraining factor which expected to limit the growth of global embryonic stem cells market. Also, stringent regulatory guidelines as well as ethical issues are major factors expected to hinder the growth of the human embryonic stem cells market.
Market Segmentation
The Global Human Embryonic Stem Cells Market is segmented into product type such as Totipotent Stem Cell, Pluripotent Stem Cell, Unipotent stem Cell. By application, market segmented into Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, and Toxicology Testing. By end user, market is segmented into Therapeutics Companies, Cell & Tissue Banks, Tools & Reagents Companies, Others.
Regional Analysis
Global Human Embryonic Stem Cells Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
North America is anticipated to gain highest share in the market over the forecast period due to the high prevalence of cardiac & malignant diseases and increase in focus in the development of cell line-based therapies in this region, especially in the United States. Moreover, APAC is also expected to witness significant growth in the global human embryonic stem cells market due to the increasing burden of chronic diseases & government support for Human Embryonic Stem Cells research in the region.
Key Players
Takara Bio Inc., ViaCyte Inc., PromoCell GmbH, STEMCELL Technologies Inc., Merck KgaA, PeproTech Inc., Astellas Pharma Inc., Thermo Fisher Scientific, Lineage Cell Therapeutics Inc., etc. 
Market Taxonomy
By product Type
•        Totipotent Stem Cell
•        Pluripotent Stem Cell
•        Unipotent stem Cell
By Application
•        Regenerative Medicine
•        Stem Cell Biology Research
•        Tissue Engineering
•        Toxicology Testing
By End User
•        Therapeutics Companies
•        Cell & Tissue Banks
•        Tools & Reagents Companies
•        Others
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa
 

Global Human Embryonic Stem Cells Market TOC:
1 Introduction        
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Human Embryonic Stem Cells Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Human Embryonic Stem Cells Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type 
5.2 Global Human Embryonic Stem Cells Market Share Analysis, By Product Type 
5.3 Global Human Embryonic Stem Cells Market Size and Forecast, By Product Type
5.3.1 Totipotent Stem Cell
5.3.2. Pluripotent Stem Cell
5.3.3. Unipotent stem Cell
6 Global Human Embryonic Stem Cells Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Human Embryonic Stem Cells Market Share Analysis, By Application
6.3 Global Human Embryonic Stem Cells Market Size and Forecast, By Application
6.3.1 Regenerative Medicine
6.3.2. Stem Cell Biology Research
6.3.3. Tissue Engineering
6.3.4. Toxicology Testing
7 Global Human Embryonic Stem Cells Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Human Embryonic Stem Cells Market Share Analysis, By End User
7.3 Global Human Embryonic Stem Cells Market Size and Forecast, By End User
7.3. 1 Therapeutics Companies
7.3.2. Cell & Tissue Banks
7.3.3. Tools & Reagents Companies
7.3.4. Others
8 Global Human Embryonic Stem Cells Market, By Region
8.1 Global Human Embryonic Stem Cells Market Share Analysis, By Region
8.2 Global Human Embryonic Stem Cells Market Share Analysis, By Region
8.3 Global Human Embryonic Stem Cells Market Size and Forecast, By Region
9 North America Human Embryonic Stem Cells Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Human Embryonic Stem Cells Market Share Analysis, By Product Type
9.3 North America Human Embryonic Stem Cells Market Size and Forecast, By Application
9.4 North America Human Embryonic Stem Cells Market Size and Forecast, By End User
9.5 North America Human Embryonic Stem Cells Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Human Embryonic Stem Cells Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Human Embryonic Stem Cells Market Share Analysis, By Product Type 
10.3 Europe Human Embryonic Stem Cells Market Size and Forecast, By Application 
10.4 Europe Human Embryonic Stem Cells Market Size and Forecast, By End User
10.5 Europe Human Embryonic Stem Cells Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Human Embryonic Stem Cells Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Human Embryonic Stem Cells Market Share Analysis, By Product Type 
11.3 Asia Pacific Human Embryonic Stem Cells Market Size and Forecast, By Application 
11.4 Asia Pacific Human Embryonic Stem Cells Market Size and Forecast, By End User
11.5 Asia Pacific Human Embryonic Stem Cells Market Size and Forecast, By Country
11.5.1 China        
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Human Embryonic Stem Cells Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Human Embryonic Stem Cells Market Share Analysis, By Product Type 
12.3 Latin America Human Embryonic Stem Cells Market Size and Forecast, By Application 
12.4 Latin America Human Embryonic Stem Cells Market Size and Forecast, By End User
12.5 Latin America Human Embryonic Stem Cells Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Human Embryonic Stem Cells Market Analysis and Forecast (2022-2027)
13.1 Introduction
 13.2 Middle East Human Embryonic Stem Cells Market Share Analysis, By Product Type 
13.3 Middle East Human Embryonic Stem Cells Market Size and Forecast, By Application 
13.4 Middle East Human Embryonic Stem Cells Market Size and Forecast, By End User
13.5 Middle East Human Embryonic Stem Cells Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Takara Bio Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. ViaCyte Inc
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. PromoCell GmbH
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 STEMCELL Technologies Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Merck KgaA
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 PeproTech Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Astellas Pharma Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies        
15.8 Thermo Fisher Scientific
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Lineage Cell Therapeutics Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies